Papa Alfredo, Danese Silvio, Grillo Antonino, Gasbarrini Giovanni, Gasbarrini Antonio
Department of Internal Medicine, Catholic University of Rome, Rome, Italy.
Am J Gastroenterol. 2003 Jun;98(6):1247-51. doi: 10.1111/j.1572-0241.2003.07491.x.
Individuals with inflammatory bowel disease frequently experience increased systemic thromboembolic complications, which represent an important cause of morbidity and mortality. Risk factors for thrombosis can be inherited or acquired. The most common inherited risk factors for thromboembolism are factor V Leiden mutation, G20210A mutation in the prothrombin gene, and homozygous C677T mutation in the methylenetetrahydrofolate reductase gene. In the last few years, a great amount of literature has focused on the prevalence of such genetic mutations and their role in determining thrombosis in IBD patients. In this review, we summarize the results of these studies.
炎症性肠病患者常常会出现全身性血栓栓塞并发症增加的情况,这是发病和死亡的一个重要原因。血栓形成的危险因素可以是遗传性的或后天获得的。最常见的遗传性血栓栓塞危险因素是凝血因子V Leiden突变、凝血酶原基因的G20210A突变以及亚甲基四氢叶酸还原酶基因的纯合子C677T突变。在过去几年中,大量文献聚焦于这些基因突变的患病率及其在确定炎症性肠病患者血栓形成中的作用。在本综述中,我们总结了这些研究的结果。